advertisement

WGA Rescources

Zhang K 13

Showing records 1 to 13 | Display all abstracts from Zhang K

112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Li R
BMJ open 2023; 13: e073219
112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
Zhang K
Investigative Ophthalmology and Visual Science 2023; 64: 32
112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Zhang K
BMJ open 2023; 13: e073219
112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
Cai W
Investigative Ophthalmology and Visual Science 2023; 64: 32
112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Lu Z
BMJ open 2023; 13: e073219
112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
Xin Y
Investigative Ophthalmology and Visual Science 2023; 64: 32
112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Mou D
BMJ open 2023; 13: e073219
112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
He Q; Chen C
Investigative Ophthalmology and Visual Science 2023; 64: 32
112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Wang J
BMJ open 2023; 13: e073219
112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
Zeng M
Investigative Ophthalmology and Visual Science 2023; 64: 32
112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Li H
BMJ open 2023; 13: e073219
112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
Chen S
Investigative Ophthalmology and Visual Science 2023; 64: 32
112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Fan S; Wang N; Liu H
BMJ open 2023; 13: e073219

Issue 24-3

Change Issue


advertisement

Nidek